Gilenya is indicated for the treatment of adult patients and pediatric patients of 10 years of age and above with relapsing forms of multiple sclerosis (MS) to reduce the frequency of clinical exacerbations and to delay the accumulation of physical disability.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
